McC+R&D Consulting combines extensive expertise and experience in Pharmaceutical R&D - both in Biotech and Big Pharma - and particularly in:

• All the different phases of Drug Discovery and Early Development: target identification; target validation; drug discovery screening cascade from hit-to-lead optimisation to clinical candidate selection; preclinical & early clinical development.
• Research and Scientific knowledge, more specifically in Biochemistry, Biology and Pharmacology, and in several key disease areas, especially in Diabetes and related Metabolic Diseases, including Obesity, Cardiovascular and Liver Diseases, and also in Inflammation, including Irritable Bowel Diseases.
• Leadership and Management in cross-organizational and multi-cultural environments.
• Driving initiation and progression of Discovery Projects into Development, with a strong track record of delivery of several high quality drug development candidates, some of which have now reached the market or are in clinical development.
• External contractual research through an extensive CROs and academic international network; scientific collaboration; joint venture; alliance; partnership.
• Scientific evaluation; due diligence; strategy and business plans; in- and out-licensing; intelligence; portfolio management; business development.